Literature DB >> 24841072

Risk of Recurrence of Preexisting Ocular Toxoplasmosis during Pregnancy.

Michael Reich1, Mira Ruppenstein, Matthias D Becker, Friederike Mackensen.   

Abstract

PURPOSE: Comparison between the risk of recurrence during pregnancy with nonpregnant periods in patients with ocular toxoplasmosis (OT).
METHODS: Records of 40 women were retrospectively reviewed. The women were subdivided into either a pregnant group or a control group formed by nonpregnant women during follow-up. Comparable cases from the literature were added. Mean number of recurrences per year was compared.
RESULTS: Eleven women with pregnancies could be included. Six cases from the literature were added (total n = 17). Mean number of recurrences per year during versus not during pregnancy was 0.16 (SD 0.39) versus 0.32 (SD 0.30; p = 0.088), respectively. In the control group (n = 29) the mean number of recurrences per year (0.31; SD 0.27) was significantly higher when compared to cases during pregnant periods (p = 0.002).
CONCLUSION: Adding to published series, the presented data do not provide evidence for a relevant impact of pregnancy on recurrence behavior in OT.

Entities:  

Keywords:  Ocular toxoplasmosis; posterior uveitis; pregnancy; prognosis; uveitis

Mesh:

Year:  2014        PMID: 24841072     DOI: 10.3109/09273948.2014.916306

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  3 in total

Review 1.  Ocular changes during pregnancy.

Authors:  Friederike Mackensen; Wolfgang E Paulus; Regina Max; Thomas Ness
Journal:  Dtsch Arztebl Int       Date:  2014-08-18       Impact factor: 5.594

2.  Activation of toxoplasma retinochoroiditis during pregnancy and evaluation of ocular findings in newborns.

Authors:  Fatih Mehmet Türkcü; Alparslan Şahin; Harun Yüksel; Yasin Çınar; Kürşat Cingü; Suat Altındağ; Özcan Deveci; Zeynep Özkurt; İhsan Çaça
Journal:  Int Ophthalmol       Date:  2016-08-01       Impact factor: 2.031

3.  Resistance to Chronic Toxoplasma gondii Infection Induced by a DNA Vaccine Expressing GRA16.

Authors:  Ling-Ying Hu; Nian-Zhang Zhang; Fu-Kai Zhang; Meng Wang; Qi Gao; Jin-Lei Wang; Xing-Quan Zhu
Journal:  Biomed Res Int       Date:  2017-08-10       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.